Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Hormone refractory prostate cancer.

Literature DB >> 10606277

Hormone refractory prostate cancer.

E D Crawford¹, M Rosenblum, A M Ziada, P H Lange.

Abstract

Entities: Disease

Mesh：

Substances：
Antineoplastic Agents

Year: 1999 PMID： 10606277 DOI： 10.1016/s0090-4295(99)00447-1

Source DB: PubMed Journal: Urology ISSN： 0090-4295 Impact factor: 2.649

Keyword Cloud
Cited

× No keyword cloud information.

10 in total

1. A mathematical investigation of the multiple pathways to recurrent prostate cancer: comparison with experimental data.

Authors: Trachette L Jackson
Journal: Neoplasia Date: 2004 Nov-Dec Impact factor: 5.715

2. Androgen and its receptor promote Bax-mediated apoptosis.

Authors: Yuting Lin; John Kokontis; Fangming Tang; Bradley Godfrey; Shutsung Liao; Anning Lin; Youting Chen; Jialing Xiang
Journal: Mol Cell Biol Date: 2006-03 Impact factor: 4.272

3. Prostate cancer immunotherapy yields superior long-term survival in TRAMP mice when administered at an early stage of carcinogenesis prior to the establishment of tumor-associated immunosuppression at later stages.

Authors: Andrew Gray; Maria de la Luz Garcia-Hernandez; Myrna van West; Shreya Kanodia; Bolyn Hubby; W Martin Kast
Journal: Vaccine Date: 2009-12-30 Impact factor: 3.641

4. Oleanane triterpenoid CDDO-Me inhibits growth and induces apoptosis in prostate cancer cells by independently targeting pro-survival Akt and mTOR.

Authors: Dorrah Deeb; Xiaohua Gao; Hao Jiang; Scott A Dulchavsky; Subhash C Gautam
Journal: Prostate Date: 2009-06-01 Impact factor: 4.104

5. Butanol fraction containing berberine or related compound from nexrutine inhibits NFkappaB signaling and induces apoptosis in prostate cancer cells.

Authors: Sri Balasubashini Muralimanoharan; A B Kunnumakkara; Bhaskaran Shylesh; Kaustubh H Kulkarni; Xu Haiyan; Hu Ming; Bharat B Aggarwal; Ghosh Rita; Addanki P Kumar
Journal: Prostate Date: 2009-04-01 Impact factor: 4.104

Hormone refractory prostate cancer.

1. A mathematical investigation of the multiple pathways to recurrent prostate cancer: comparison with experimental data.

2. Androgen and its receptor promote Bax-mediated apoptosis.

3. Prostate cancer immunotherapy yields superior long-term survival in TRAMP mice when administered at an early stage of carcinogenesis prior to the establishment of tumor-associated immunosuppression at later stages.

4. Oleanane triterpenoid CDDO-Me inhibits growth and induces apoptosis in prostate cancer cells by independently targeting pro-survival Akt and mTOR.

5. Butanol fraction containing berberine or related compound from nexrutine inhibits NFkappaB signaling and induces apoptosis in prostate cancer cells.

Review 6. Prostate stem cell antigen: a prospective therapeutic and diagnostic target.

Review 7. DNA vaccination: using the patient's immune system to overcome cancer.

8. Anisomycin activates JNK and sensitises DU 145 prostate carcinoma cells to Fas mediated apoptosis.

9. Study of NGEP expression in androgen sensitive prostate cancer cells: A potential target for immunotherapy.

10. Monitoring luciferase-labeled human prostate stem cell antigen-expressing tumor growth in a mouse model.